Topsoe Christina Teng's Form 4 filing
IGM Biosciences, Inc. (IGMS) · filed Jul 5, 2023
- Accession no.
- 0001209191-23-041391
- Filed
- Jul 5, 2023
- Trade date
- Jun 30, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $28.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Topsoe Christina TengCIK 0001786442 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | Common Stock | PPurchaseAcquired | +3,000 | $9.32F1 | +$27,960 | 9,800 | Indirect | |
| Jun 30, 2023 | Common Stock | AGrant or awardAcquired | +738 | $0.00 | $0 | 39,443 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $9.31 to $9.34. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
Referenced by the price of 1 transaction in Table I.